Bio-Conscious Technologies Inc.: federal grants and contributions: 3 agreements; $1.6M value; 3 departments; 3 programs.
Assay record ASY-CA-01MLYNU10H · Cite as: Assay Systems, “Bio-Conscious Technologies Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/bio-conscious-technologies-inc/
Commercialize an AI platform for diabetes management
The proposed project concerns the design and development of two principal software components of a novel Machine Learning approach to the detection of Alzheimer's Disease, through use of Continuous Blood Glucose Monitoring.
The purpose of this CanExport - Innovation (CXI) grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other countries to allow them to proceed with formal discussions to initiate collaboration(s) on future international R&D initiatives that could lead to commercialization of Canadian technologies.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.